Sutro Biopharma Inc: Planned 50 Patients in Dose-Optimization (Part 1) of RefrΑMe-O1 Have Been Enrolled and Are in Follow up
Sutro Biopharma Inc:計劃進行劑量優化(第 1 部分)的 50 名患者已入組並正在接受隨訪
Sutro Biopharma Inc: Planned 50 Patients in Dose-Optimization (Part 1) of RefrΑMe-O1 Have Been Enrolled and Are in Follow up
Sutro Biopharma Inc:計劃進行劑量優化(第 1 部分)的 50 名患者已入組並正在接受隨訪
使用瀏覽器的分享功能,分享給你的好友吧